| Date | Title | Description |
| 01.02.2024 | SPR Therapeutics Raises $85M in Additional Funding | SPR Therapeutics, a Cleveland, OH-based private medical device company focused on treating pain and improving the quality of life for patients managing acute or chronic pain, raised $85m in financing.
This included $25m in Series D-1 inside... |
| 01.02.2024 | SPR Therapeutics Raises $85M |
CLEVELAND, OH, SPR Therapeutics today announced that it has secured $85 million in financing including $25 million in Series D-1 insider equity and a $60 million debt facility.
>> Click here for more funding data on SPR Therapeutic... |
| 15.06.2022 | Pain Management Therapeutics Market to Reach an Estimated Value of US$ 92,123.4 Mn by 2027 | TMR Image
Pain Management Therapeutics Market - Global Industry Analysis, Size, Share, Growth, Trends, and Forecast 2019 - 2027
WILMINGTON, DELAWARE, USA, June 15, 2022 /EINPresswire.com/ -- Transparency Market Research (TMR) has published ... |
| 10.05.2022 | Veterinary Pain Management Market to Reach a value of US$ 1.97 Billion by 2027 | CAGR of 7.0% | Veterinary Pain Management Market SHERIDAN, ALABAMA, UNITED STATES, May 10, 2022 /EINPresswire.com/ -- According to the latest report by IMARC Group, titled “Veterinary Pain Management Market: Global Industry Trends, Share, Size, Growth, Op... |
| 29.04.2022 | United States Pain Management Therapeutics Market Analysis Report 2022: Market Size was Valued at $6.75 Billion in 2021 and will Reach $12.55 Billion in 2028 | Dublin, April 29, 2022 (GLOBE NEWSWIRE) -- The "United States Pain Management Therapeutics Market, Forecast 2022-2028, Industry Trends, Outlooks, Impact of COVID-19, Company Analysis" report has been added to ResearchAndMarkets.co... |
| 10.03.2022 | Postoperative Pain Management Market growth is predicted at 5% CAGR to reach a valuation of US$ 57.8 Bn by 2031 | NEW YORK, March 10, 2022 (GLOBE NEWSWIRE) -- Rising prevalence of postoperative pain, emergence of potential treatment therapies, and development of novel drug delivery approaches are some of the many factors that are expected to drive the ... |
| 19.10.2021 | SPR Therapeutics runs up $37M VC funding for Sprint pain relief device | Even with the surge in pharmaceutical and technological innovation of recent decades, the goal of developing a drug or device for nonaddictive, surgery-free and lasting pain relief remains an elusive one.
Aiming to be among the first to cro... |
| 19.10.2021 | SPR Therapeutics runs up $37M VC funding for Sprint pain relief device | Even with the surge in pharmaceutical and technological innovation of recent decades, the goal of developing a drug or device for nonaddictive, surgery-free and lasting pain relief remains an elusive one.
Sponsored by Quotient Sciences Simp... |
| 19.10.2021 | SPR Therapeutics scores $37M for pain relief tool and other digital health fundings | Photo: Kwanchai Lerttanapunyaporn/EyeEm/Getty Images |
| 18.10.2021 | SPR Therapeutics Closes $37 Million Growth Equity Financing for Commercial Expansion of its SPRINT® PNS System | CLEVELAND, Oct. 18, 2021 (GLOBE NEWSWIRE) -- SPR Therapeutics, a private medical device company focused on providing patients with pain relief without opioids or surgery, announced today it has raised $37 million in an oversubscribed Series... |
| 18.10.2021 | SPR Therapeutics Closes $37 Million Growth Equity Financing for Commercial Expansion of its SPRINT® PNS System | – Expanding U.S. Commercial Team Amid Record-Breaking Growth –
CLEVELAND, Oct. 18, 2021 (GLOBE NEWSWIRE) -- SPR Therapeutics, a private medical device company focused on providing patients with pain relief without opioids or surgery, announ... |
| 18.10.2021 | SPR Therapeutics Closes $37 Million Growth Equity Financing for Commercial Expansion of its SPRINT® PNS System | CLEVELAND, Oct. 18, 2021 (GLOBE NEWSWIRE) -- SPR Therapeutics, a private medical device company focused on providing patients with pain relief without opioids or surgery, announced today it has raised $37 million in an oversubscribed Series... |
| 18.09.2017 | 2 contrasting medtech approaches to deal with chronic pain and avoid opioids | “Chronic pain is challenging to manage. Having real-time data can provide more information about patients’ quality of life changes,” said Dr. Lance Roy, pain medicine specialist at Duke University Medical Center, in a Medtronic news release... |
| 13.09.2017 | SPR Therapeutics gets $25M for pain management wearable | SPR Therapeutics, the Cleveland, Ohio-based developer of a wearable pain management device, announced yesterday the completion of $25 million in Series C financing. The company’s new funding — primarily secured from Frontcourt Ventures and ... |
| 13.09.2017 | SPR Therapeutics raises $25 million in Series C financing | SPR Therapeutics Inc., a medical device company in Highland Hills that has developed a neurostimulation platform for chronic and acute pain, announced on Tuesday morning, Sept. 12, that it has received $25 million in Series C financing.
The... |
| 12.09.2017 | Term Sheet — Tuesday, September 12 | ROBOT LAWYER
Good morning, Term Sheet readers.
Paid Content You can't secure what you can't see From ExtraHop
EQUIFAX SAGA: OK, this is my favorite story of the day. After the Equifax security breach left more than 143 million Americans vul... |
| 12.09.2017 | SPR Therapeutics Snags $25M Series C Round |
CLEVELAND, OH, SPR Therapeutics, (SPR) a private medical device company that has developed a novel neurostimulation technology for chronic and acute pain, announced today the completion of $25 million in Series C Financing.
>> Clic... |
| 12.09.2017 | SPR Therapeutics Raises $25M in Series C Funding | SPR Therapeutics, a Cleveland, OH-based medical device startup, raised $25M in Series C funding.
A prominent family office and Frontcourt Ventures led the round.
The company intends to use the capital to commercialize its FDA-cleared SPRINT... |
| 15.05.2017 | SPR Therapeutics awarded $6 million U.S. Department of Defense grant | SPR Therapeutics has secured a $6 million contract from the U.S. Department of Defense for its non-opioid pain management therapy.
The four-year contract will help to advance SPR's SPRINT Peripheral Nerve Stimulation (PNS) System for non-op... |
| 28.07.2016 | FDA gives nod to first fully-removable percutaneous peripheral nerve stimulation device | On Wednesday, Boston Scientific announced that it’s acquiring a company that makes radio-frequency ablation devices, underscoring the need to offer medtech alternatives to treating chronic pain, which is overwhelmingly addressed by drugs.
A... |
| 04.06.2015 | Neuromodulation: 5 cutting-edge startups deploying this tech | Some of the longest-running work in neuromodulation is being done at the medical device giants – Medtronic, for instance, has had a long-standing neuromodulation program. Boston Scientific and St. Jude Medical are also top contenders.
But s... |
| 06.04.2015 | SPR Therapeutics to receive $1.45 million grant from National Institutes of Health | SPR Therapeutics will receive a $1.45 million grant that it will use to develop an implantable version of its nerve stimulation system, which is used to treat post-amputation pain. The Highland Hills-based company is in the process of testi... |
| 15.01.2013 | SPR Therapeutics raises $5M Series A round | Cleveland-area startup SPR Therapeutics closed a $7.8 million Series A financing round to commercialize its neurostimulation pain relief device.
The funding came from NDI Healthcare Fund, Public Square Partners and individual investors, acc... |
| 09.01.2013 | SPR Therapeutics Raises $5M Series A |
CLEVELAND, OH, SPR Therapeutics has raised $5 million in Series A financing from NDI Healthcare Fund, Public Square Partners, and individual investors.
>> Click here for more funding data on SPR Therapeutics
>> To export SPR... |
| 08.01.2013 | Neurostimulation device firm SPR Therapeutics expands series A to $5M, awaits CE Mark | It’s also awaiting CE Mark certification, which Bennett said she anticipates getting the official OK “any day now.”
In its initial application, the device will address post-stroke shoulder pain.
The Smartpatch comprises an external stimulat... |
| 08.01.2013 | SPR Therapeutics Raises $5M in Series A Financing | SPR Therapeutics, a Cleveland, OH-based neurodevice firm, raised $5m in Series A financing.
Backers included NDI Healthcare Fund, Public Square Partners, and individual investors.
The company intends to use the funding to commercialize pain... |
| 20.09.2012 | SPR Therapeutics OK’ed for pivotal trial of device to treat post-stroke shoulder pain | SPR’s device is made up of an external stimulator that snaps on to an adhesive patch placed on the skin. The stimulator connects to a single lede that’s placed into the deltoid muscle by a physician in an office-based procedure.
Patients us... |
| 24.01.2012 | SPR Therapeutics Raises $2.2M |
CLEVELAND, OH, NDI Medical led the round in SPR, whose pain-relief system is aimed at reducing shoulder pain in patients who've suffered strokes.
>> Click here for more funding data on SPR Therapeutics
>> To export SPR Thera... |
| 19.10.2011 | Pain-relief device startup SPR Therapeutics ups series A to $1M | SPR’s first product, the minimally invasive Smartpatch, is aimed at reducing shoulder pain in patients who’ve suffered strokes. The technology works via an external generator that electrically stimulates a peripheral nerve to exercise a mus... |
| 27.04.2011 | SPR Therapeutics Recieves $250K from JumpStart Ventures | SPR Therapeutics, a one-year-old Beachwood, Ohio-based company that is commercializing its proprietary neurostimulation therapy for pain relief, has recieved a $250,000 investment from JumpStart Ventures.
SPR Therapeutics, a spinoff of NDI ... |
| 27.04.2011 | SPR Therapeutics lands $250,000 from JumpStart | Neurostimulation company SPR Therapeutics LLC received a $250,000 investment from JumpStart to help develop and commercialize its pain relief medical device.
SPR’s first product, the minimally invasive Smartpatch, is aimed at reducing shoul... |
| 26.04.2011 | Neurotech firm SPR Therapeutics gets $250K JumpStart investment | “I am thrilled to have JumpStart Ventures’ support in our mission to provide clinicians with a simple and effective therapy to reduce or eliminate their patients’ pain and ultimately improve their patients’ quality of life,” Bennett said in... |
| 11.04.2011 | Neurotech startup SPR Therapeutics readies for launch of pain relief device | SPR’s first product, the minimally invasive Smartpatch, is aimed at reducing shoulder pain in patients who’ve suffered strokes. The technology works via an external generator that electrically stimulates a peripheral nerve to exercise a mus... |
| 15.07.2009 | Biomedical engineer knows her technology and her business | Bennett expects to network with would-be investors during the reception, but she’s already done quite a few investor pitches trying to raise between $6 million and $8 million for SPR Therapeutics. SPR, which stands for Stimulation for Pa... |
| - | 2 contrasting medtech approaches to deal with chronic pain and avoid opioids | As the nation battles the opioid crisis, medtech companies are relying on versions of a technology that they hope will make a real dent in how chronic pain is treated and managed: neurostimulation.
On Monday, Medtronic announced that FDA ha... |
| - | Pain-relief device startup SPR Therapeutics ups series A to $1M | Neurotechnology pain-relief device company SPR Therapeutics has increased its series A round of investment to $1 million and hopes to push the number up to $2 million, according to a regulatory document.
CEO Maria Bennett said earlier this ... |
| - | FDA gives nod to first fully-removable percutaneous peripheral nerve stimulation device | On Wednesday, Boston Scientific announced that it’s acquiring a company that makes radio-frequency ablation devices, underscoring the need to offer medtech alternatives to treating chronic pain, which is overwhelmingly addressed by drugs.
A... |
| - | Neuromodulation: 5 cutting-edge startups deploying this tech | Neuromodulation has been around a long time, but in recent years it’s picking up steam as a haute, beyond-the-pill technology.
The concept of neuromodulation is quite simple: It’s an emerging branch of medicine that treats the nervous syste... |
| - | Biomedical engineer knows her technology and her business | WASHINGTON, D.C. — Maria Bennett is attending a White House briefing and a reception on Capitol Hill this afternoon — not the usual activities of a biomedical engineer-turned-CEO.
Bennett is being honored by Springboard Enterprises in Washi... |
| - | SPR Therapeutics | - |
| - | SPR Therapeutics OK’ed for pivotal trial of device to treat post-stroke shoulder pain | A minimally invasive device to relieve shoulder pain after stroke is heading to phase 3 trials by the end of this year.
SPR Therapeutics has been cleared by the FDA to begin a pivotal study of its Smartpatch Peripheral Nerve Stimulation Sys... |
| - | Pain management device firm ReGear raises $500K | Pain management medical device company ReGear Life Sciences has raised $500,000 to boost its sales and marketing efforts.
The Pittsburgh-based company’s portable, 4-pound, pain management device, called the ReBound, works by generating heat... |
| - | Neurotech startup SPR Therapeutics readies for launch of pain relief device | Assuming all goes well in a federal regulatory review, neurotechnology startup SPR Therapeutics expects to begin commercializing its first product, a pain relief device, by the end of the year.
Year-old SPR (it stands for “stimulation for p... |
| - | Neurotech firm SPR Therapeutics gets $250K JumpStart investment | Neurostimulation company SPR Therapeutics has received a $250,000 investment from JumpStart to help develop and commercialize its pain relief medical device.
SPR’s first product, the minimally invasive Smartpatch, is aimed at reducing shoul... |
| - | Neurostimulation device firm SPR Therapeutics expands series A to $5M, awaits CE Mark | Cleveland-based medical device company SPR Therapeutics has upped its series A yet again and raised an additional $2.8 million, which brings its total to $5 million from NDI Healthcare Fund, Public Square Partners and individual investors.
... |
